CLBT vs LASR
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CLBT shows bullish fundamentals based on deterministic rules. Financial strength is strong (F-Score 7/9). Key strengths include strong valuation and growth metrics. Price trades at a 370.1% premium to fair value estimate ($3.01), limiting near-term upside from a valuation perspective.
LASR exhibits a severe disconnect between its parabolic price action (+831% 1Y) and its fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While revenue growth is explosive at 71.3%, the company remains unprofitable with negative margins and an extreme Forward P/E of 131.03. The combination of a bearish technical trend (10/100) and aggressive insider selling by the CEO and CFO suggests the stock is currently priced for perfection and is highly vulnerable to a correction.
Compare Another Pair
Related Comparisons
CLBT vs LASR: Head-to-Head Comparison
This page compares Cellebrite DI Ltd. (CLBT) and nLIGHT, Inc. (LASR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.